XNAS · Healthcare · Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Q1 2026 | 0.61 | 0.30 | -50.82% | $173.9M | ❌ Miss | -19.70% | -32.66% | — |
| 2026-02-24 | Q4 2025 | 0.39 | 0.57 | +46.15% | $160.8M | ✅ Beat | +6.70% | +7.42% | -25.82% |
| 2025-10-29 |
| Q3 2025 |
| 0.36 |
| 0.66 |
| +83.33% |
| $143.8M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-30 | Q2 2025 | 0.45 | 0.92 | +104.44% | $157.4M | ✅ Beat | +12.25% | +10.31% | +6.74% |
| 2025-02-27 | Q4 2024 | 0.16 | 0.19 | +18.75% | $121.6M | ✅ Beat | +5.82% | -9.47% | -6.71% |
| 2024-10-28 | Q3 2024 | 0.30 | 0.12 | -60.00% | $108.8M | ❌ Miss | -29.90% | -32.69% | -31.00% |
| 2024-07-31 | Q2 2024 | 0.21 | 0.35 | +66.67% | $114.3M | ✅ Beat | +6.50% | +2.52% | +18.14% |
| 2024-04-30 | Q1 2024 | -0.05 | 0.35 | +800.00% | $96.8M | ✅ Beat | +24.93% | +35.22% | +44.93% |
Showing last 8 quarters.